Cravatex Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Rajesh Batra

Chief executive officer

₹2.6m

Total compensation

CEO salary percentage	83.2%
CEO tenure	13.4yrs
CEO ownership	0.002%
Management average tenure	no data
Board average tenure	4.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Rajesh Batra's remuneration changed compared to Cravatex's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	₹44m
Jun 30 2024	n/a	n/a	₹49m
Mar 31 2024	₹3m	₹2m	₹48m
Dec 31 2023	n/a	n/a	₹82m
Sep 30 2023	n/a	n/a	₹928m
Jun 30 2023	n/a	n/a	₹705m
Mar 31 2023	₹5m	₹4m	₹589m
Dec 31 2022	n/a	n/a	₹559m
Sep 30 2022	n/a	n/a	-₹331m
Jun 30 2022	n/a	n/a	-₹200m
Mar 31 2022	₹3m	₹3m	-₹199m
Dec 31 2021	n/a	n/a	-₹271m
Sep 30 2021	n/a	n/a	-₹257m
Jun 30 2021	n/a	n/a	-₹296m
Mar 31 2021	₹2m	₹2m	-₹306m
Dec 31 2020	n/a	n/a	-₹333m
Sep 30 2020	n/a	n/a	-₹267m
Jun 30 2020	n/a	n/a	-₹116m
Mar 31 2020	₹3m	₹3m	-₹47m
Dec 31 2019	n/a	n/a	₹648k
Sep 30 2019	n/a	n/a	₹61m
Jun 30 2019	n/a	n/a	₹78m
Mar 31 2019	₹2m	₹2m	₹107m

Compensation vs Market: Rajesh's total compensation ($USD30.75K) is about average for companies of similar size in the Indian market ($USD42.67K).

Compensation vs Earnings: Rajesh's compensation has been consistent with company performance over the past year.

CEO

Rajesh Batra (69 yo)

13.4yrs

Tenure

₹2,596,152

Compensation

Mr. Rajesh Kumar Batra has been Managing Director of Cravatex Limited since June 1, 2011 and serves as its Executive Chairman. Mr. Batra co-founded Proline in 1983. Mr. Batra had been an Independent Non-Ex...

Board Members

Name	Position	Tenure	Compensation	Ownership
Rajesh Batra	Chairman & MD	43yrs	₹2.60m	0.0019% ₹ 20.9k
Divakar Kamath	Additional Executive Director & CFO	4.6yrs	₹3.11m	no data
Pheroza Bilimoria	Independent Director	10.2yrs	₹270.00k	no data
Rohan Batra	Additional Non-Executive Director	4.6yrs	₹120.00k	0.00039% ₹ 4.2k
Nakul Toshniwal	Independent Director	less than a year	no data	no data
Satyan Israni	Independent Director	less than a year	₹90.00k	no data

4.6yrs

Average Tenure

69yo

Average Age

Experienced Board: 509472's board of directors are considered experienced (4.6 years average tenure).

Cravatex Management

Management criteria checks 3/4

Key information

Recent management updates

Cravatex Limited Announces Resignation of Shivkumar Dhalumal Israni as Independent Director

Cravatex Limited Announces Resignation of Shivkumar Dhalumal Israni as Independent Director

Cravatex Limited, Annual General Meeting, Aug 04, 2023

Insufficient new directors

Cravatex Limited, Annual General Meeting, Aug 30, 2022

Recent updates

Second quarter 2025 earnings released: EPS: ₹10.26 (vs ₹12.04 in 2Q 2024)

Cravatex Limited to Report Q2, 2025 Results on Nov 13, 2024

New minor risk - Share price stability

First quarter 2025 earnings released: EPS: ₹1.87 (vs ₹1.64 in 1Q 2024)

Cravatex Limited to Report Q1, 2025 Results on Aug 12, 2024

Investor sentiment improves as stock rises 17%

Upcoming dividend of ₹3.00 per share

Dividend of ₹3.00 announced

Cravatex Limited to Report Q4, 2024 Results on May 24, 2024

Investor sentiment deteriorates as stock falls 19%

Third quarter 2024 earnings released: EPS: ₹3.05 (vs ₹330 in 3Q 2023)

Cravatex Limited to Report Q3, 2024 Results on Feb 14, 2024

Cravatex Limited Announces Resignation of Shivkumar Dhalumal Israni as Independent Director

Cravatex Limited Announces Resignation of Shivkumar Dhalumal Israni as Independent Director

Second quarter 2024 earnings released: EPS: ₹12.04 (vs ₹74.23 loss in 2Q 2023)

First quarter 2024 earnings released: EPS: ₹1.64 (vs ₹42.98 loss in 1Q 2023)

Cravatex Limited to Report Q1, 2024 Results on Aug 14, 2023

Upcoming dividend of ₹1.50 per share at 0.4% yield

Full year 2023 earnings released: EPS: ₹228 (vs ₹76.96 loss in FY 2022)

Full year 2023 earnings released: EPS: ₹228 (vs ₹76.96 loss in FY 2022)

Cravatex Limited, Annual General Meeting, Aug 04, 2023

Insufficient new directors

Third quarter 2023 earnings released: EPS: ₹330 (vs ₹14.16 loss in 3Q 2022)

Cravatex Limited to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: ₹74.23 loss per share (vs ₹23.37 loss in 2Q 2022)

Second quarter 2023 earnings released: ₹74.23 loss per share (vs ₹23.37 loss in 2Q 2022)

Cravatex Limited to Report First Half, 2023 Results on Nov 11, 2022

Metro Brands Limited (NSEI:METROBRAND) signed a share purchase agreement to acquire Cravatex Brands Limited from Cravatex Limited (BSE:509472) and Paragon Partners for an enterprise value of INR 2 billion.

Cravatex Limited Declares Final Dividend for the Financial Year 2021-2022

Upcoming dividend of ₹3.00 per share

Full year 2022 earnings released: ₹76.96 loss per share (vs ₹118 loss in FY 2021)

Cravatex Limited, Annual General Meeting, Aug 30, 2022

Cravatex Limited Proposes Final Dividend for the Financial Year 2021-22

Full year 2022 earnings released: ₹76.96 loss per share (vs ₹118 loss in FY 2021)

Cravatex Limited Recommends Dividend for the Financial Year Ended 31 March 2022

Cravatex Limited to Report Q4, 2022 Results on May 30, 2022

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Upcoming dividend of ₹3.00 per share

Full year 2021 earnings released: ₹118 loss per share (vs ₹33.08 loss in FY 2020)

New 90-day high: ₹300

Third quarter 2021 earnings released: ₹22.11 loss per share (vs ₹2.57 profit in 3Q 2020)

Cravatex Limited to Report Q3, 2021 Results on Feb 12, 2021

New 90-day low: ₹250

New 90-day low: ₹254

First quarter earnings released

New 90-day low - ₹248

CEO Compensation Analysis

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age